Clinical Trial

Personalized T-Cell Therapy iNeo-Vac-T01 in Advanced Colorectal Cancer

Name: Personalized T-Cell Therapy iNeo-Vac-T01 in Advanced Colorectal Cancer — clinical trial record (NCT07504523)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The primary objective of this study is to evaluate the feasibility, safety, and efficacy of personalized T-cell therapy based on tumor neoantigens in patients with advanced colorectal cancer, so as to provide a novel individualized therapeutic strategy for such patients.

Trial Details

NCT Number	NCT07504523
Lead Sponsor	Ying Yuan, MD Collaborators: Hangzhou Neoantigen Therapeutics Co., Ltd.
Conditions	Metastatic Colorectal Cancer (CRC)
Enrollment	20 participants
Start Date	2023-11-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-01